Page last updated: 2024-10-23

2,2-bis(4-glycidyloxyphenyl)propane and Obesity

2,2-bis(4-glycidyloxyphenyl)propane has been researched along with Obesity in 1 studies

2,2-bis(4-glycidyloxyphenyl)propane: structure

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamauchi, T1
Waki, H1
Kamon, J1
Murakami, K1
Motojima, K1
Komeda, K1
Miki, H1
Kubota, N1
Terauchi, Y1
Tsuchida, A1
Tsuboyama-Kasaoka, N1
Yamauchi, N1
Ide, T1
Hori, W1
Kato, S1
Fukayama, M1
Akanuma, Y1
Ezaki, O1
Itai, A1
Nagai, R1
Kimura, S1
Tobe, K1
Kagechika, H1
Shudo, K1
Kadowaki, T1

Other Studies

1 other study available for 2,2-bis(4-glycidyloxyphenyl)propane and Obesity

ArticleYear
Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes.
    The Journal of clinical investigation, 2001, Volume: 108, Issue:7

    Topics: 3T3 Cells; Adipose Tissue; Animals; Benzhydryl Compounds; Benzoates; Biphenyl Compounds; Diabetes Me

2001